| |
著者: Mona Marin, Mariel Marlow, Kelly L Moore, Manisha Patel
雑誌名: MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):33-38. doi: 10.15585/mmwr.mm6701a7. Epub 2018 Jan 12.
Abstract/Text
A substantial increase in the number of mumps outbreaks and outbreak-associated cases has occurred in the United States since late 2015 (1,2). To address this public health problem, the Advisory Committee on Immunization Practices (ACIP) reviewed the available evidence and determined that a third dose of measles, mumps, rubella (MMR) vaccine is safe and effective at preventing mumps. During its October 2017 meeting, ACIP recommended a third dose of a mumps virus-containing vaccine* for persons previously vaccinated with 2 doses who are identified by public health authorities as being part of a group or population at increased risk for acquiring mumps because of an outbreak. The purpose of the recommendation is to improve protection of persons in outbreak settings against mumps disease and mumps-related complications. This recommendation supplements the existing ACIP recommendations for mumps vaccination (3).
PMID 29324728 MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):33-38. doi: 10.15585/mmwr.mm6701a7. Epub 2018 Jan 12.
|
